(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LAKEFRONT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

LAKEFRONT

ST13

US500000099261757

Class

5, 42, 44

Filing

99261757

Registration

8238979

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

05/05/2026

Trademark type

Word

Nice classes

5, 42, 44

Filing date

07/01/2025

Registration date

05/05/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/05/2026

Last transaction

05/05/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Mechelen, BE

Examiner

ALESKOW, DAVID HOWARD

Law office

L50

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Galapagos NV

Representatives

Alexandra MacKay Stites & Harbison PLLC

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint diseaseinflammatory diseasesautoinflammatory diseasesautoimmune diseasesproliferative diseasescancerhematological cancersolid tumorsendocrine diseasesmetabolic diseasesskin diseaseslung diseasesfibrotic diseasescardiovascular diseasespainhepatitis B viruskidney diseasesosteoporosisosteoarthritisrheumatoid arthritisatopic dermatitisidiopathic pulmonary fibrosisinflammatory bowel diseaseCrohn's diseaseulcerative colitisankylosing spondylitispsoriatic arthritisSjogren's syndromelupusuveitissclerodermadermatomyositisurticarianon-alcoholic steatohepatitispolycystic kidney diseasetype 2 diabetes; biopharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint diseaseinflammatory diseasesautoinflammatory diseasesautoimmune diseasesproliferative diseasescancerhematological cancersolid tumorsendocrine diseasesmetabolic diseasesskin diseaseslung diseasesfibrotic diseasescardiovascular diseasespainhepatitis B viruskidney diseasesosteoporosisosteoarthritisrheumatoid arthritisatopic dermatitisidiopathic pulmonary fibrosisinflammatory bowel diseaseCrohn's diseaseulcerative colitisankylosing spondylitispsoriatic arthritisSjogren's syndromelupusuveitissclerodermadermatomyositisurticarianon-alcoholic steatohepatitispolycystic kidney diseasetype 2 diabetes

Class 42

Medical and scientific research services; industrial research in the field of pharmaceuticals; pharmaceutical and biopharmaceutical research and development services; scientific and medical research services in the nature of examining and testing of genes; pharmaceutical and biopharmaceutical drug development services featuring theexamination and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; pharmaceutical drug development services featuring theexamination and testing of medicaments; product research and development in the field of test systems for pharmaceutical and biopharmaceutical products; database development servicesconfiguration and customization of computer databases containing information regarding medicalpharmaceutical and biopharmaceutical information; pharmaceutical drug development services

Class 44

Medical services; Medical advisory services; Medical and pharmaceutical consultation; Pharmaceutical advice

Publications

History of USPTO decisions and trademark events.

16 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/05/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

05/05/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/17/2026

PUBO

PUBLISHED FOR OPPOSITION

03/17/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/11/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/19/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/19/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/18/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/18/2026

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/19/2025

GNRT

NON-FINAL ACTION E-MAILED

11/19/2025

CNRT

NON-FINAL ACTION WRITTEN

11/19/2025

DOCK

ASSIGNED TO EXAMINER

11/19/2025

MAFR

APPLICATION FILING RECEIPT MAILED

07/01/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/01/2025

NWAP

NEW APPLICATION ENTERED

07/01/2025

Continuous trademark protection

Get notified about every new filing that threatens LAKEFRONT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.